Cost-utility analysis of nonalcoholic steatohepatitis screening
2015
Objectives
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in Western countries. No studies have examined the cost-effectiveness of screening its advanced form, nonalcoholic steatohepatitis (NASH).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
103
References
40
Citations
NaN
KQI